(lp0
S'Magellan Diagnostics  Continues ... Yahoo Finance - Mar 7, 2017 CINCINNATI, March 07, 2017  -- Meridian Bioscience, Inc.  announced today that Magellan Diagnostics Inc., a business unit of Meridian since March 2016, has signed an exclusive distribution agreement with Biofirm Technologies,&nbsp;...'
p1
aS'BRIEF-Meridian Bioscience Inc signs an exclusive distribution agreement with ... Reuters - Mar 7, 2017 WASHINGTON, March 7 Wall Street dealmaking attorney Jay Clayton will appear before the U.S. Senate Banking Committee on March 23 for his confirmation hearing to become the next chairman of the Securities and Exchange Commission.'
p2
aS"Here's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day Motley Fool - Jan 25, 2017 Shares of Meridian Bioscience, Inc. , a diagnostics-focused life-science company, fell hard at the open Wednesday, and were still off about 19.8% at 12:01 p.m.Meridian Bioscience stock drops 9% on first-quarter earnings and revenue ... - MarketWatch"
p3
aS'Pawar Law Group Announces Investigation of Securities Claims Against Meridian ... Yahoo Finance - Feb 7, 2017 NEW YORK, NY / ACCESSWIRE / February 7, 2017 / The Pawar Law Group announces it is investigating potential securities claims on behalf of shareholders of Meridian Bioscience, Inc.   resulting from allegations that management&nbsp;...'
p4
aS'Common Share Dividend Yield of Meridian Bioscience Inc.  Energy Index - 22 hours ago The dividend growth rate of Meridian Bioscience  calculated based on 20 historical quarterly dividends is 1.49% while the R-Squared dividend growth rate regression is 0.72.'
p5
aS'Meridian Bioscience, Inc. Receives FDA Clearance for New Molecular Test for ... GlobeNewswire  - Jun 15, 2016 CINCINNATI, June 15, 2016  -- Meridian Bioscience, Inc.  today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia (M.'
p6
aS'Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results ... GlobeNewswire  - Nov 10, 2016 reported fourth quarter fiscal 2016 net earnings of $5.5 million, or $0.13 per diluted share, on a GAAP basis, a 35% decrease compared to the fiscal 2015 fourth quarter.'
p7
aS'Bioline Launches New JetSeq DNA Library Preparation Kits GlobeNewswire  - Feb 8, 2017 CINCINNATI, Feb. 08, 2017  -- Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc.  today announced the expansion of the JetSeq DNA Library Preparation portfolio for Next Generation&nbsp;...'
p8
aS'Meridian Bioscience  Completes Acquisition of Magellan Biosciences StreetInsider.com - Mar 24, 2016 Meridian Bioscience, Inc.,  announced that it has completed the acquisition of Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. Headquartered in Billerica, Massachusetts , Magellan&nbsp;...Cincinnati public company makes acquisition - Cincinnati Business CourierLead-test maker Magellen Diagnostics acquired for $66m - The Boston Globe'
p9
aS'SHAREHOLDER ALERT: Bronstein, Gewirtz &amp; Grossman, LLC Announces Investigation ... Yahoo Finance - Jan 25, 2017 25, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Meridian Bioscience, Inc.  . Such investors can obtain&nbsp;...'
p10
a.